Search

Your search keyword '"Araujo, Carla"' showing total 430 results

Search Constraints

Start Over You searched for: Author "Araujo, Carla" Remove constraint Author: "Araujo, Carla"
430 results on '"Araujo, Carla"'

Search Results

1. The Impact of Excluding Adverse Neonatal Outcomes on the Creation of Gestational Weight Gain Charts Among Women from Low- and Middle-income Countries with Normal and Overweight BMI

3. REDES SOCIAIS E VACINAS: O QUE A PANDEMIA DO SARS-COV-2 TEM A NOS ENSINAR?

6. Elevated serum IL-6 levels predict treatment interruption in patients with moderate to severe psoriasis: a 6-year real-world cohort study

8. Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 study

9. Early referral to nephrological care improves long-term survival and hospitalization after dialysis initiation, independent of optimal dialysis start – a call for harmonization of reimbursement policies.

10. Behavioural disinhibition in frontotemporal dementia investigated within an ecological framework

11. Carfilzomib maintenance in newly diagnosed non-transplant eligible multiple myeloma

13. Testing reproducibility of vitrinite and solid bitumen reflectance measurements in North American unconventional source-rock reservoir petroleum systems

16. CONSTRUÇÃO DE UMA EMBARCAÇÃO SOLAR PARA COMPETIÇÃO UNIVERSITÁRIA

18. Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

23. Pomalidomide, cyclophosphamide, and dexamethasone for relapsed multiple myeloma

24. Exploring the molecular complexity of Triatoma dimidiata sialome

30. Percutaneous coronary intervention reduces mortality in myocardial infarction patients with comorbidities: Implications for elderly patients with diabetes or kidney disease

32. Salvage therapy post pomalidomide-based regimen in relapsed/refractory myeloma

34. Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low–Tumor Burden Follicular Lymphoma: Results of a LYSA Study

35. Mulheres negras: enfrentamentos e resiliência

36. Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma

38. VTD is superior to VCD prior to intensive therapy in multiple myeloma: results of the prospective IFM2013-04 trial

39. Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study

40. Smart city como promotora de qualidade de vida, atividade física e saúde: análise da cidade que acolhe a COP 30 - Belém.

41. Pomalidomide and dexamethasone until progression after first salvage therapy in multiple myeloma

42. Behavioural disinhibition in frontotemporal dementia investigated within an ecological framework

48. Standardization of reflectance measurements in dispersed organic matter: Results of an exercise to improve interlaboratory agreement

49. Multicenter Open Label Phase 2 Study of Isatuximab Plus Pomalidomide and Dexamethasone with Carfilzomib in Relapsed or Refractory Multiple Myeloma. Iskpd - IFM2018-03

50. A Dexamethasone Sparing-Regimen with Daratumumab and Lenalidomide in Frail Patients with Newly-Diagnosed Multiple Myeloma: Efficacy and Safety Analysis of the Phase 3 IFM2017-03 Trial

Catalog

Books, media, physical & digital resources